Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Symptoms of Schizophrenia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00573417
What this trial is testing

A Placebo-Controlled Trial of Modafinil (Provigil) Added to Clozapine in Patients With Schizophrenia

Who this might be right for
Schizophrenia
North Suffolk Mental Health Association 40
Testing effectiveness (Phase 2)Ended earlyNCT03044249
What this trial is testing

MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression

Who this might be right for
PsychosisDementiaAggression+2 more
Mediti Pharma Inc. 81
Post-approval studies (Phase 4)Study completedNCT01050478
What this trial is testing

IMPACT: A Study to Explore the Efficacy and Safety of Paliperidone ER in Patients With Acute Agitation

Who this might be right for
Psychomotor AgitationAcute Disease
Janssen Cilag N.V./S.A. 56
Not applicableStudy completedNCT03467243
What this trial is testing

Evaluating the Use of Peer Specialists to Deliver Cognitive Behavioral Social Skills Training

Who this might be right for
Serious Mental Illness
VA Office of Research and Development 191
Large-scale testing (Phase 3)Study completedNCT03325556
What this trial is testing

Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis

Who this might be right for
Dementia-related Psychosis
ACADIA Pharmaceuticals Inc. 392
Testing effectiveness (Phase 2)Looking for participantsNCT04917302
What this trial is testing

Combination of NMDA-enhancing and Anti-inflammatory Treatments for Schizophrenia

Who this might be right for
Schizophrenia
China Medical University Hospital 60
Very early researchUnknownNCT06235177
What this trial is testing

Psychoneuromentalism Disorder: A Medical Condition That Affects People With Psychological Impairments From Health Issues

Who this might be right for
Schizoaffective Disorder, Bipolar TypeBipolar DisorderADHD - Combined Type+5 more
The Essence of Integrative Health and Medicine Practice 30
Not applicableNot Yet RecruitingNCT07393464
What this trial is testing

PQQ for Cognitive and Negative Symptoms

Who this might be right for
SchizophreniaCognitive SymptomsNegative Symptoms
Tianjin Anding Hospital 70
Testing effectiveness (Phase 2)Ended earlyNCT01568216
What this trial is testing

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Who this might be right for
Schizophrenia
Amgen 121
Testing effectiveness (Phase 2)Study completedNCT01450514
What this trial is testing

POC Study of Pipamperone Added to Stable Treatment With RIS or PAL in Chronic Schizophrenia

Who this might be right for
Chronic SchizophreniaSchizoaffective Disorder
PharmaNeuroBoost N.V. 7
Not applicableUnknownNCT02378818
What this trial is testing

Characterization of the Motivational Deficit in Schizophrenia and Depression

Who this might be right for
SchizophreniaDepression
Centre Hospitalier St Anne 140
Not applicableEnded earlyNCT03648268
What this trial is testing

Using Transcranial Magnetic Stimulation (TMS) to Understand 'Negative' Symptoms of Schizophrenia

Who this might be right for
SchizophreniaNegative Type; SchizophrenicSchizo Affective Disorder
Beth Israel Deaconess Medical Center 47
Not applicableStudy completedNCT02340559
What this trial is testing

Effectiveness of Meta-Cognitive Training (EMC) in People With Psychosis of Brief Evolution.

Who this might be right for
Psychosis
Fundació Sant Joan de Déu 122
Not applicableStudy completedNCT01924715
What this trial is testing

Evaluating the Cost Effectiveness of ISTDP: A Quasi Experimental Study

Who this might be right for
AnxietySomatoform DisordersPersonality Disorders+2 more
Nova Scotia Health Authority 1,082
Testing effectiveness (Phase 2)Study completedNCT00063297
What this trial is testing

Safety and Efficacy of Study Drug Versus Placebo for Negative Symptoms of Schizophrenia

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 180
Not applicableUnknownNCT04256720
What this trial is testing

The Multi-Ethnic Lifestyle Study

Who this might be right for
Diabetes MellitusChronic Kidney DiseasesCardiovascular Diseases+7 more
University of Leicester 9,500
Not applicableUnknownNCT02137616
What this trial is testing

Antipsychotic to Treat Psychosis Syndrome

Who this might be right for
Psychotic Disorders
Central South University 300
Large-scale testing (Phase 3)Study completedNCT00035802
What this trial is testing

Evaluate the Safety and Effectiveness of Topiramate Compared to Placebo in the Treatment of Patients With Bipolar I Disorder

Who this might be right for
Bipolar DisorderAffective Disorders, PsychoticMood Disorders+1 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 13
Not applicableStudy completedNCT00753506
What this trial is testing

Artemisinin to Reduce The Symptoms of Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
Sheppard Pratt Health System 66
Large-scale testing (Phase 3)Study completedNCT00148447
What this trial is testing

The Efficacy of Escitalopram for Negative Symptoms in Schizophrenia

Who this might be right for
Schizophrenia
BeerYaakov Mental Health Center 40
Next Page